The feasibility of using conversational agent technology to improve problem-solving and coping skills of young adults with cancer
Marlene M von Friederichs-Fitzwater1, Frederick J Meyers2
1Division of Hematology/Oncology, Internal Medicine, 2School of Medicine, University of California Davis, Sacramento, CA, USA
Objective: Young adults with cancer have unique psychosocial needs and often lack the problem-solving and coping skills for effective resolution. We conducted a study to clarify these needs and then developed and tested an educational intervention to coach young adults with cancer in problem-solving and coping skills using a new conversational agent technology that uses a multi-media format to simulate face-to-face encounters.
Methods: We qualitatively assessed online focus groups and chat rooms with 45 young adults with cancer and used the results to develop and test an online 15-minute educational prototype using a new conversational agent technology with 49 young adults (18–35 years of age) with cancer.
Results: Young adults with cancer are most concerned about reproductive issues, emotional issues, communicating with healthcare providers, and the risks and benefits of treatments. The study participants found the I-COPE prototype to be useful, easy to use, and worth recommending to others. They wanted to have more video segments about the experiences of other young adults with cancer; more video segments of actual procedures and treatments; more Internet links to information and resources; and more opportunities to interact with the conversational agent.
Conclusion: New conversational agent technology is useful in coaching problem-solving and coping skills to empower young adults with cancer.
Practice implications: New conversational agent technology is a useful tool in patient education and skill development, particularly among young adults.
Keywords: young adult cancer patients, conversational agent technology, problem-solving, coping, self-efficacy, survivorship
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]